Prentice Capital Management LP 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Immunome, Inc. IMNM |
Prentice Capital Management LP | 498,145 4.110% |
-421,917 (-45.86%) |
Filing |
| 2022-02-14 4:30 pm Purchase |
2021-12-31 | 13G | Immunome, Inc. IMNM |
Prentice Capital Management LP | 920,062 7.600% |
142,894 (+18.39%) |
Filing |
| 2021-12-03 11:13 am Purchase |
2021-12-02 | 13G | Immunome, Inc. IMNM |
Prentice Capital Management LP | 777,168 6.420% |
777,168 (New Position) |
Filing |